4.8 Article

Third DWF1 paralog in Solanaceae, sterol Delta(24)-isomerase, branches withanolide biosynthesis from the general phytosterol pathway

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1807482115

关键词

sterol biosynthesis; Withania somnifera; sterol 24-isomerase; withanolides; pathway evolution

资金

  1. Carlsberg Foundation
  2. Japan Society for the Promotion of Science (JSPS)
  3. JSPS KAKENHI
  4. NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001840] Funding Source: NIH RePORTER

向作者/读者索取更多资源

A large part of chemodiversity of plant triterpenes is due to the modification of their side chains. Reduction or isomerization of double bonds in the side chains is often an important step for the diversification of triterpenes, although the enzymes involved are not fully understood. Withanolides are a large group of structurally diverse C-28 steroidal lactones derived from 24-methylenecholesterol. These compounds are found in the Indian medicinal plant Withania somnifera, also known as ashwagandha, and other members of the Solanaceae. The pathway for withanolide biosynthesis is unknown, preventing sustainable production via white biotechnology and downstream pharmaceutical usages. In the present study, based on genome and transcriptome data we have identified a key enzyme in the biosynthesis of withanolides: a DWF1 paralog encoding a sterol Delta(24)-isomerase (24ISO). 24ISO originated from DWF1 after two sub-sequent duplication events in Solanoideae plants. Withanolides and 24ISO appear only in the medicinal plants in the Solanoideae, not in crop plants such as potato and tomato, indicating negative selection during domestication. 24ISO is a unique isomerase enzyme evolved from a reductase and as such has maintained the FAD-binding oxido-reductase structure and requirement for NADPH. Using phylogenetic, metabolomic, and gene expression analysis in combination with heterologous expression and virus-induced gene silencing, we showed that 24ISO catalyzes the conversion of 24-methylenecholesterol to 24-methyldesmosterol. We propose that this catalytic step is the committing step in withanolide biosynthesis, opening up elucidation of the whole pathway and future larger-scale sustainable production of withanolides and related compounds with pharmacological properties.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据